Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Clark VC, Strange C, Strnad P, Sanchez AJ, et al. Gastroenterology 2024;167:1008-1018.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Clark VC, Strange C, Strnad P, Sanchez AJ, et al. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology 2024;167:1008-1018.
PMID: 38964420